There are signs that doctors may be moving away from experimental precision therapy options in favor of immunotherapy and the chance at longer survival.
In a survey of 132 oncologists, Medscape tracked how they are using next-generation sequencing and what they think of its clinical utility.
There is significant interest in technologies that provide long-range genomic information, but only among a subset of users.
Only 5 percent of respondents said they got tested through a consumer genomics firm, but the future market could be worth as much as $7 billion, analysts at UBS estimated.
Researchers examined the patient-physician relationship after sharing personal genetic testing results and found that patients may have certain expectations.
A Vanderbilt University survey revealed most clinicians don't need convincing PGx testing is useful, but they don't agree which provider is responsible for the next step.
Around 70 percent of cancer compounds and 40 percent of compounds for all indications are being developed with biomarker data.
Poor patient health, tumor histology, insufficient tissue samples, and long turnaround times are some reasons doctors gave for not using EGFR status to determine care.
The survey, conducted by GenomeWeb in conjunction with investment bank William Blair, found that users operate their NGS instruments at different capacities.
After going through the consumer genomics testing process, participants maintained similar, high levels of genetic literacy, but reported lower confidence in their understanding of genetic information.
Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.
Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.
China is embracing preimplantation genetic diagnosis, Nature News reports.
In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.